MENLO PARK, CA--(Marketwire - November 18, 2008) - SRI International, an independent, nonprofit research and development organization, announced today that it has been awarded a $1,788,011 contract by the National Institute on Drug Abuse (NIDA). The award is a continuation of two previous NIDA contracts for which SRI has provided chemical analysis of synthetic peptides and related compounds, as well as drugs of abuse. SRI's program will be managed by Kanthi Hettiarachchi, Ph.D., senior chemist in SRI's Biosciences Division.
